Zydus Cadila receives USFDA approval for Exemestane tablet
Zydus Cadila has received final USFDA approval to market Exemestane tablets, used for treatment of breast cancer. The drug in the strength of 25 mg […]
Cadila
Cadila receives USFDA approval to market Tadalafil in US
Zydus Cadila has received final USFDA approval to market Tadalafil tablets in American markets. The drug Tadalafil is used to erectile dysfunction and enlarged prostrate. […]
Cadila Healthcare receives USFDA approval for Ethacrynate sodium
Zydus Cadila has received final USFDA approval to market Ethacrynate sodium for injection, used to reduce swelling caused by various diseases. The company will market […]
Zydus Cadila receives USFDA approval for minocycline hydrochloride
Zydus Cadila has received final USFDA approval to market minocycline hydrochloride extended release tablets used to treat acne. The company will market the drug in […]
Cadila Healthcare receives USFDA approval for aspirin and extended release dipyridamole capsules
Zydus Cadila has received final USFDA approval to market aspirin and extended release dipyridamole capsules, which is used to prevent excessive blood clotting and reduce […]
Cadila receives USFDA approval for candesartan cilextil
Zydus Cadila has received final USFDA approval to market candesartan cilexetil tablets used for treatment of hypertension. The company will market the drug in the […]
Cadila receives USFDA approval for Tidalyt ER and Azelastine Hydrochloride
Cadila Healthcare has received final USFDA approval to market blood pressure drug, Tiadylt ER. The drug diltiazem hydrochloride (Tiadylt ER) extended release capsules will be […]
Cadila receives USFDA approval for Pindolol tablets
Zydus Cadila has received final USFDA approval to market Pindolol tablets in USA, which is used for treatment of hypertension. The company will market the […]
Cadila has received USFDA approval for Telmisartan and Hydrochlorothiazide tablets
Zydus Cadila has received final USFDA approval to market Telmisartan and Hydrochlorothiazide tablets used in the treatment of hypertension. The company will market the drug […]
Zydus Cadila receives USFDA approval for Temozolomide and Nadolol
Zydus Cadila has received the final USFDA approval to market Temozolomide capsules in USA. The drug will be available in strengths of 5 mg, 20 […]